Skip to main content
Log in

Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy

  • Head and Neck Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Histologic grade of tumor is one of the major prognostic predictors for patients with salivary gland cancer. Because of disease rarity, little is known about the optimal treatment modalities and outcomes in low-grade salivary gland cancers (LGSGC). We tried to identify prognostic factors, and the adequate treatment modalities and outcomes in pathologically confirmed LGSGC patients.

Methods

We retrospectively extracted the clinical and pathology data from 179 LGSGC cases from 1995 to 2013. Pathological features, such as extraparenchymal extension, perineural/nerve invasion, lymphovascular invasion/tumor emboli, and resection margin status were redefined for each case. Risk factors for recurrence, extent of surgery, and the role of postoperative radiation therapy were analyzed.

Results

Recurrence-free survival and overall survival were 89.6 and 96.6 % at 10 years, respectively. The presence of regional nodal metastasis and positive cancer cells at resection margin were significant unfavorable prognostic factors. Postoperative adjuvant radiation treatment significantly reduced recurrences, particularly in cases with pathology risk factors (perineural invasion, lymphovascular invasion, extraparenchymal extension, or cancer cells at the resection margin), node metastasis, and advanced T-stage tumors. Close surgical margin <5 mm was not a significant risk factor for recurrence, and less-than-total resection of the affected gland did not increase recurrence, if surgery could achieve a cancer cell-free surgical margin.

Conclusion

Postoperative radiation clearly benefitted patients with pathology risk factors, node metastasis, and advanced T stage in LGSGC. Meanwhile, the oncological outcomes are very good with surgery alone in cases of pT1-2N0 LGSGC without pathology risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Huang AT, Tang C, Bell D, et al. Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015;51:610–5.

    Article  PubMed  Google Scholar 

  2. Adelstein DJ, Koyfman SA, El-Naggar AK, Hanna EY. Biology and management of salivary gland cancers. Semin Radiat Oncol. 2012;22:245–53.

    Article  PubMed  Google Scholar 

  3. Tumours of the salivary glands. In: Barnes L, Everson JW, Reichart P, Sidransky D (eds). World Health Organization classification of tumors: pathology and genetics: head and neck tumors. Lyon: IARC Press; 2005. p. 209–81.

    Google Scholar 

  4. Brandwein MS, Ferlito A, Bradley PJ, Hille JJ, Rinaldo A. Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol. 2002;122:758–64.

    Article  PubMed  Google Scholar 

  5. Seifert G, Sobin LH. The World Health Organization’s histological classification of salivary gland tumors. A commentary on the second edition. Cancer. 1992;70:379–85.

    Article  CAS  PubMed  Google Scholar 

  6. Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg. 2005;133:702–8.

    Article  PubMed  Google Scholar 

  7. Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005;63:917–28.

    Article  PubMed  Google Scholar 

  8. Walvekar RR, Andrade Filho PA, Seethala RR, et al. Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies. Head Neck. 2011;33:225–31.

    Article  PubMed  PubMed Central  Google Scholar 

  9. McHugh CH, Roberts DB, El-Naggar AK, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012;118:3928–36.

    Article  PubMed  Google Scholar 

  10. Jegadeesh N, Liu Y, Prabhu RS, et al. Outcomes and prognostic factors in modern era management of major salivary gland cancer. Oral Oncol. 2015;51:770–7.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Richter SM, Friedmann P, Mourad WF, Hu KS, Persky MS, Harrison LB. Postoperative radiation therapy for small, low-/intermediate-grade parotid tumors with close and/or positive surgical margins. Head Neck. 2012;34:953–5.

    Article  PubMed  Google Scholar 

  12. Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys. 1997;37:79–85.

  13. Gomez DR, Katabi N, Zhung J, et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer. 2009;115:2128–37.

    Article  PubMed  Google Scholar 

  14. Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck. 2004;26:681–92. discussion 92–3.

    Article  PubMed  Google Scholar 

  15. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.

    Article  PubMed  Google Scholar 

  16. Batsakis JG, Luna MA. Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol. 1990;99:835–8.

    Article  CAS  PubMed  Google Scholar 

  17. Nance MA, Seethala RR, Wang Y, et al. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer. 2008;113:2082–9.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54:1062–9.

    Article  CAS  PubMed  Google Scholar 

  19. Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009;3:69–77.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Noh JM, Ahn YC, Nam H, et al. Treatment results of major salivary gland cancer by surgery with or without postoperative radiation therapy. Clin Exp Otorhinolaryngol. 2010;3:96–101.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Haderlein M, Scherl C, Semrau S, et al. High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype. Head Neck. 2016;38 Suppl 1:E2041–8.

    Article  PubMed  Google Scholar 

  22. Kim BY, Hyeon J, Ryu G, et al. Diagnostic accuracy of fine needle aspiration cytology for high-grade salivary gland tumors. Ann Surg Oncol. 2013;20:2380–7.

    Article  PubMed  Google Scholar 

  23. Jeong HS, Chung MK, Son YI, et al. Role of 18F-FDG PET/CT in management of high-grade salivary gland malignancies. J Nucl Med. 2007;48:1237–44.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST; 2015R1D1A1A09056771) and the Samsung Biomedical Research Institute (SBRI) 2016 basic-clinical collaborative research grant.

Funding

The above funders had no further role in the study design, collection, analysis and interpretation of data, writing of the manuscript, or in the decision to submit this manuscript for publication.

Conflict of interest

Jae-Keun Cho, Byung-Woo Lim, Eun-Hye Kim, Young-Hyeh Ko, Dongryul Oh, Jae-Myoung Noh, Yong Chan Ahn, Kwan-Hyuck Baek, and Han-Sin Jeong have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Kwan-Hyuck Baek PhD or Han-Sin Jeong MD, PhD.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 23 kb)

Supplementary material 2 (DOCX 79 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cho, JK., Lim, BW., Kim, EH. et al. Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy. Ann Surg Oncol 23, 4368–4375 (2016). https://doi.org/10.1245/s10434-016-5353-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5353-6

Keywords

Navigation